Verdecchia P, Reboldi G, Angeli F. The 2020 International Society of Hypertension global hypertension practice guide-lines-key messages and clinical considerations. Eur J Intern Med. 2020;82:1–6. https://doi.org/10.1016/j.ejim.2020.09.001.

Article  PubMed  Google Scholar 

Pistoia F, Sacco S, Degan D, Tiseo C, Ornello R, Carolei A. Hypertension and Stroke: Epidemiological Aspects and Clinical Evaluation. High Blood Press Cardiovasc Prev. 2016;2:9–18. https://doi.org/10.1007/s40292-015-0115-2.

Article  Google Scholar 

Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflamm. 2017;2017:5620314. https://doi.org/10.1155/2017/5620314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Youn JY, Cai H. Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension. J Hypertens. 2015;33:1128–36. https://doi.org/10.1097/HJH.0000000000000587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liakos CI, Vyssoulis GP, Michaelides AP, Chatzistamatiou EI, Theodosiades G, Toutouza MG, Markou MI, Synetos AG, Kallikazaros IE, Stefanadis CI. The effects of angiotensin receptor blockers vs. calcium channel blockers on the acute exercise-induced inflammatory and thrombotic response. Hypertens Res. 2012;35:1193–200. https://doi.org/10.1038/hr.2012.134.

Article  CAS  PubMed  Google Scholar 

Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond). 2006;30:1308–14. https://doi.org/10.1038/sj.ijo.0803189.

Article  CAS  PubMed  Google Scholar 

Jacobs A, Schutte AE, Ricci C, Pieters M. Plasminogen activator inhibitor-1 activity and the 4G/5G polymorphism are prospectively associated with blood pressure and hypertension status. J Hypertens. 2019;37:2361–70. https://doi.org/10.1097/HJH.0000000000002204.

Article  CAS  PubMed  Google Scholar 

Tabak O, Gelisgen R, Uzun H, Kalender B, Balci H, Curgunlu A, Simsek G, Karter Y, Simsek G, Karter Y. Hypertension and hemostatic/fibrinolytic balance disorders. Clin Invest Med. 2009;32:285–90. https://doi.org/10.25011/cim.v32i6.10664.

Article  Google Scholar 

Hirschl MM, Bur A, Woisetschlaeger C, Derhaschnig U, Laggner AN. Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients. J Clin Hypertens (Greenwich). 2007;9:430–5. https://doi.org/10.1111/j.1524-6175.2007.06506.x.

Article  CAS  PubMed  Google Scholar 

Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Adv Exp Med Biol. 2017;956:511–40. https://doi.org/10.1007/5584-2016-90.

Article  PubMed  Google Scholar 

Blann AD, Naqvi T, Waite M, McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993;7:107–11.

CAS  PubMed  Google Scholar 

Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 1997;80:1566–71. https://doi.org/10.1016/s0002-9149(97)00749-2.

Article  CAS  PubMed  Google Scholar 

Yang P, Liu YF, Yang L, Wei Q, Zeng H. Mechanism and Clinical Significance of the Prothrombotic State in Patients with Essential Hypertension. Clin Cardiol. 2010;33(E81–6):E81–6. https://doi.org/10.1002/clc.20719.

Article  PubMed  PubMed Central  Google Scholar 

Souilhol C, Serbanovic-Canic J, Fragiadaki M, Chico TJ, Ridger V, Roddie H, Evans PC. Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes. Nat Rev Cardiol. 2020;17:52–63. https://doi.org/10.1038/s41569-019-0239-5.

Article  PubMed  Google Scholar 

Chistiakov DA, Orekhov AN, Bobryshev YV. Effects of shear stress on endothelial cells: go with the flow. Acta Physiol (Oxf). 2017;219:382–408. https://doi.org/10.1111/apha.12725.

Article  CAS  PubMed  Google Scholar 

Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960. https://doi.org/10.1155/2014/406960.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biguzzi E, Castelli F, Lijfering WM, Cannegieter SC, Eikenboom J, Rosendaal FR, van Hylckama VA. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. Thromb Res. 2020;197:172–8. https://doi.org/10.1016/j.thromres.2020.11.016.

Article  CAS  PubMed  Google Scholar 

Spencer CG, Felmeden DC, Blann AD, Lip GY. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. J Intern Med. 2007;261:82–90. https://doi.org/10.1111/j.1365-2796.2006.01735.x.

Article  CAS  PubMed  Google Scholar 

Grandl G, Wolfrum C. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol. 2018;40(2):215–24. https://doi.org/10.1007/s00281-017-0666-5.

Article  CAS  PubMed  Google Scholar 

Lim HS, Lip GYH, Blann AD. Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab. 2004;89:5377–81. https://doi.org/10.1210/jc.2004-0616.

Article  CAS  PubMed  Google Scholar 

Karaman M, Balta S, Seyit Ahmet AY, Cakar M, Naharci I, Demirkol S, Celik T, Arslan Z, Kurt O, Kocak N, Sarlak H, Demirbas S, Bulucu F, Bozoglu E. The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens. 2013;35:516–22. https://doi.org/10.3109/10641963.2012.758734.

Article  CAS  PubMed  Google Scholar 

Mansfield MW, Heywood DM, Grant PJ. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996;16:160–4. https://doi.org/10.1161/01.atv.16.1.160.

Article  CAS  PubMed  Google Scholar 

Wägner AM, Wiebe JC, Boronat M, Saavedra P, Marrero D, Varillas F, Nóvoa FJ. Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study. J Endocrinol Invest. 2011;34:e409–12. https://doi.org/10.3275/7325.

Article  CAS  PubMed  Google Scholar 

Srikumar N, Brown NJ, Hopkins PN, Jeunemaitre X, Hunt SC, Vaughan DE, Williams GH. PAI-1 in human hypertension: relation to hypertensive groups. Am J Hypertens. 2002;15:683–90. https://doi.org/10.1016/s0895-7061(02)02952-7.

Article  CAS  PubMed  Google Scholar 

Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, Salvetti A. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension. 2001;37:9432–48. https://doi.org/10.1161/01.hyp.37.3.943.

Article  Google Scholar 

Yang R, Tang J, Kuang M, Liu H. Analysis of prescription status of Antihypertensive drugs in Chinese patients hypertension based on real-world study. Ann Med. 2023;55:276–84. https://doi.org/10.1080/07853890.2022.2162113.

Article  CAS  PubMed  PubMed Central  Google Scholar